Rainer Storb, MD

Member and Head of Transplantation Biology Program
Clinical Research Division
Professor of Medicine, Oncology
University of Washington

Education:

University of Munich, 1957, Physikum
University of Freiburg, 1960, State Medical Examination
University of Freiburg, 1960, MD
 

Research Focus:

Transplantation biology; basic and translational research into the biology of allogeneic blood and marrow hematopoietic cell transplantation (HCT)

  • Developing radically different approaches for HCT that have minimal toxicity, do not ablate the marrow, and thus are safe enough to administer in the ambulatory care setting.
  • Extending treatment with HCT from related and unrelated donors to include elderly and medically infirm patients with advanced hematologic malignancies and eradicating underlying disease with immunologic graft-vs-tumor effects.
  • Applying minimal-intensity conditioning regimens to treat patients with serious non-malignant blood disorders, such as aplastic anemia, hemoglobinopathies and immune deficiency diseases, by allogeneic HCT.
  • Develop novel methods for preventing acute GVHD and treating chronic GVHD in animal models based on mechanistic studies.
  • Investigating graft-host tolerance by establishing transient mixed hematopoietic chimerism as a prelude for acceptance of solid organ transplants.
     

Clinical Expertise:

  • Allogeneic HCT for patients with advanced malignant and non-malignant blood disorders
  • Prevention of graft-vs-host disease
     


file

Contact Information

Phone
(206) 667-4407
Fax
(206) 667-6124
Email
Additional contact

Mail Stop: D1-100